Literature DB >> 21302180

Testing an optimized community-based human immunodeficiency virus (HIV) risk reduction and antiretroviral adherence intervention for HIV-infected injection drug users.

Michael M Copenhaver1, I-Ching Lee, Arthur Margolin, Robert D Bruce, Frederick L Altice.   

Abstract

The authors conducted a preliminary study of the 4-session Holistic Health for HIV (3H+), which was adapted from a 12-session evidence-based risk reduction and antiretroviral adherence intervention. Improvements were found in the behavioral skills required to properly adhere to HIV medication regimens. Enhancements were found in all measured aspects of sex-risk reduction outcomes, including HIV knowledge, motivation to reduce sex-risk behavior, behavioral skills related to engaging in reduced sexual risk, and reduced risk behavior. Improvements in drug use outcomes included enhancements in risk reduction skills as well as reduced heroin and cocaine use. Intervention effects also showed durability from post-intervention to the follow-up assessment point. Females responded particularly well in terms of improvements in risk reduction skills and risk behavior. This study suggests that an evidence-based behavioral intervention may be successfully adapted for use in community-based clinical settings where HIV-infected drug users can be more efficiently reached.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21302180      PMCID: PMC3071583          DOI: 10.1080/08897077.2011.540466

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  18 in total

1.  Urban women's negotiation strategies for safer sex with their male partners.

Authors:  S P Williams; P S Gardos; B Ortiz-Torres; S Tross; A A Ehrhardt
Journal:  Women Health       Date:  2001

2.  Effectiveness, transportability, and dissemination of interventions: what matters when?

Authors:  S K Schoenwald; K Hoagwood
Journal:  Psychiatr Serv       Date:  2001-09       Impact factor: 3.084

3.  Modeling the use of innovations in private treatment organizations: the role of absorptive capacity.

Authors:  Hannah K Knudsen; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2004-01

Review 4.  Intervening effectively with drug abusers infected with HIV: taking into account the potential for cognitive impairment.

Authors:  Michael Copenhaver; S Kelly Avants; Lara A Warburton; Arthur Margolin
Journal:  J Psychoactive Drugs       Date:  2003 Apr-Jun

5.  We don't train in vain: a dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy.

Authors:  Diane E Sholomskas; Gia Syracuse-Siewert; Bruce J Rounsaville; Samuel A Ball; Kathryn F Nuro; Kathleen M Carroll
Journal:  J Consult Clin Psychol       Date:  2005-02

Review 6.  Changing AIDS-risk behavior.

Authors:  J D Fisher; W A Fisher
Journal:  Psychol Bull       Date:  1992-05       Impact factor: 17.737

7.  A randomized clinical trial of a manual-guided risk reduction intervention for HIV-positive injection drug users.

Authors:  Arthur Margolin; S Kelly Avants; Lara A Warburton; Keith A Hawkins; Julia Shi
Journal:  Health Psychol       Date:  2003-03       Impact factor: 4.267

8.  A randomized controlled trial to reduce HIV transmission risk behaviors and sexually transmitted diseases among women living with HIV: The WiLLOW Program.

Authors:  Gina M Wingood; Ralph J DiClemente; Isis Mikhail; Delia L Lang; Donna Hubbard McCree; Susan L Davies; James W Hardin; Edward W Hook; Michael Saag
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

9.  Clinician-initiated HIV risk reduction intervention for HIV-positive persons: Formative Research, Acceptability, and Fidelity of the Options Project.

Authors:  Jeffrey D Fisher; Deborah H Cornman; Chandra Y Osborn; K Rivet Amico; William A Fisher; Gerald A Friedland
Journal:  J Acquir Immune Defic Syndr       Date:  2004-10-01       Impact factor: 3.731

10.  Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy.

Authors:  S Kelly Avants; Arthur Margolin; Mary Helen Usubiaga; Cheryl Doebrick
Journal:  J Subst Abuse Treat       Date:  2004-03
View more
  13 in total

1.  Rationale and design of an integrated bio-behavioral approach to improve adherence to pre-exposure prophylaxis and HIV risk reduction among opioid-dependent people who use drugs: The CHRP-BB study.

Authors:  Roman Shrestha; Frederick L Altice; Brian Sibilio; Jude Ssenyonjo; Michael M Copenhaver
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

2.  Harm reduction: compassionate care of persons with addictions.

Authors:  Robin Bartlett; Laura Brown; Mona Shattell; Thelma Wright; Lynne Lewallen
Journal:  Medsurg Nurs       Date:  2013 Nov-Dec

3.  Viral suppression among HIV-infected methadone-maintained patients: The role of ongoing injection drug use and adherence to antiretroviral therapy (ART).

Authors:  Roman Shrestha; Michael M Copenhaver
Journal:  Addict Behav       Date:  2018-05-31       Impact factor: 3.913

4.  Treatment Engagement Moderates the Effect of Neurocognitive Impairment on Antiretroviral Therapy Adherence in HIV-Infected Drug Users in Treatment.

Authors:  Roman Shrestha; Pramila Karki; Tania B Huedo-Medina; Michael Copenhaver
Journal:  J Assoc Nurses AIDS Care       Date:  2016-09-22       Impact factor: 1.354

5.  Public health implications for adequate transitional care for HIV-infected prisoners: five essential components.

Authors:  Sandra A Springer; Anne C Spaulding; Jaimie P Meyer; Frederick L Altice
Journal:  Clin Infect Dis       Date:  2011-09       Impact factor: 9.079

6.  The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS.

Authors:  Ifeoma Ezeabogu; Michael M Copenhaver; Jessica Potrepka
Journal:  AIDS Care       Date:  2012-01-17

7.  Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence.

Authors:  Albert M Anderson; Melinda K Higgins; Raymond L Ownby; Drenna Waldrop-Valverde
Journal:  AIDS Care       Date:  2014-12-06

8.  A non-inferiority trial of an evidence-based secondary HIV prevention behavioral intervention compared to an adapted, abbreviated version: Rationale and intervention description.

Authors:  Roman Shrestha; Archana Krishnan; Frederick L Altice; Michael Copenhaver
Journal:  Contemp Clin Trials       Date:  2015-08-05       Impact factor: 2.226

Review 9.  ART uptake and adherence among women who use drugs globally: A scoping review.

Authors:  Jennifer L Glick; Aimee Huang; Rienna Russo; Belinda Jivapong; Vijayasundaram Ramasamy; Lori Rosman; Danielle Pelaez; Katherine H A Footer; Susan G Sherman
Journal:  Drug Alcohol Depend       Date:  2020-08-02       Impact factor: 4.492

10.  Development and preliminary evaluation of a behavioural HIV-prevention programme for teenage girls of Latino descent in the USA.

Authors:  Tatiana M Davidson; Cristina M Lopez; Raelle Saulson; April L Borkman; Kathryn Soltis; Kenneth J Ruggiero; Michael de Arellano; Gina M Wingood; Ralph J Diclemente; Carla Kmett Danielson
Journal:  Cult Health Sex       Date:  2014-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.